New Jatrophane-Type Diterpenoids from Euphorbia kansui as Potential MDR Reversal Agents

Chem Biodivers. 2022 Nov;19(11):e202200660. doi: 10.1002/cbdv.202200660. Epub 2022 Oct 17.

Abstract

A serial jatrophane-type diterpenoids, comprised with three undescribed compounds kanesulones C-E (1-3) and four known ones (4-7), were obtained from the roots of Euphorbia kansui. The structures of compounds 1-3 were elucidated by detailed interpretation of their spectroscopic data, especially 2D-NMR and HR-ESI-MS, the absolute configuration of 1 was revealed by single crystal X-ray diffraction. These isolates were assayed for their multidrug resistance reversing activities on human breast adenocarcinoma cell line MCF-7/ADR. Compound 1 possessed potential as low toxic MDR modulator that could promote the efficacy of anticancer drug adriamycin ca. 85-fold at 5 μM, as 12 times stronger than the positive drug verapamil.

Keywords: Euphorbia kansui; MDR reversal; diterpenoid; jatrophane.

MeSH terms

  • Diterpenes* / chemistry
  • Diterpenes* / pharmacology
  • Drug Resistance, Multiple
  • Euphorbia* / chemistry
  • Humans
  • Molecular Structure

Substances

  • jatrophane
  • Diterpenes